Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of ADAM10 in Alzheimer’s Disease
Xiang‐Zhen Yuan, Sen Sun, Chen‐Chen Tan, et al.
Journal of Alzheimer s Disease (2017) Vol. 58, Iss. 2, pp. 303-322
Closed Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

GWAS on family history of Alzheimer’s disease
Riccardo E. Marioni, Sarah E. Harris, Qian Zhang, et al.
Translational Psychiatry (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 521
Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics
Maryam Raeeszadeh‐Sarmazdeh, Linh Do, Brianne Hritz
Cells (2020) Vol. 9, Iss. 5, pp. 1313-1313
Open Access | Times Cited: 258
Alzheimer’s Disease: An Updated Overview of Its Genetics
Jesús Andrade-Guerrero, Alberto Santiago-Balmaseda, Paola Jeronimo-Aguilar, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3754-3754
Open Access | Times Cited: 171
Age-related immune alterations and cerebrovascular inflammation
Carson Finger, Inés Moreno‐González, Antonia Gutiérrez, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 2, pp. 803-818
Open Access | Times Cited: 114
Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review)
Xiaolu Zhang, Ziyu Wang, Yujia Zheng, et al.
International Journal of Molecular Medicine (2023) Vol. 51, Iss. 4
Open Access | Times Cited: 57
The Amyloid Cascade Hypothesis in Alzheimer’s Disease: Should We Change Our Thinking?
Markku Kurkinen, Michał Fułek, Katarzyna Fułek, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 453-453
Open Access | Times Cited: 45
A single nuclear transcriptomic characterisation of mechanisms responsible for impaired angiogenesis and blood-brain barrier function in Alzheimer’s disease
Stergios Tsartsalis, Hannah Sleven, Nurun Fancy, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 28
TIGAR: An Improved Bayesian Tool for Transcriptomic Data Imputation Enhances Gene Mapping of Complex Traits
Sini Nagpal, Xiaoran Meng, Michael P. Epstein, et al.
The American Journal of Human Genetics (2019) Vol. 105, Iss. 2, pp. 258-266
Open Access | Times Cited: 111
Molecular Pharmacology of Rosmarinic and Salvianolic Acids: Potential Seeds for Alzheimer’s and Vascular Dementia Drugs
Solomon Habtemariam
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 2, pp. 458-458
Open Access | Times Cited: 89
Targeting ADAM10 in Cancer and Autoimmunity
Timothy M. Smith, Anuj Tharakan, Rebecca Martin
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 89
Phosphorylation Signaling in APP Processing in Alzheimer’s Disease
Tao Zhang, Dongmei Chen, Tae Ho Lee
International Journal of Molecular Sciences (2019) Vol. 21, Iss. 1, pp. 209-209
Open Access | Times Cited: 88
Alzheimer disease pathology and the cerebrospinal fluid proteome
Loı̈c Dayon, Antonio Núñez Galindo, Jérôme Wojcik, et al.
Alzheimer s Research & Therapy (2018) Vol. 10, Iss. 1
Open Access | Times Cited: 85
Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands
Aida Iraji, Mahsima Khoshneviszadeh, Omidreza Firuzi, et al.
Bioorganic Chemistry (2020) Vol. 97, pp. 103649-103649
Closed Access | Times Cited: 83
Truncation of Tau selectively facilitates its pathological activities
Jianlan Gu, Wen Xu, Nana Jin, et al.
Journal of Biological Chemistry (2020) Vol. 295, Iss. 40, pp. 13812-13828
Open Access | Times Cited: 73
New insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer’s disease
Jiaojiao Wu, Yang Yu, Yan Wan, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 152, pp. 113207-113207
Open Access | Times Cited: 67
MOSTWAS: Multi-Omic Strategies for Transcriptome-Wide Association Studies
Arjun Bhattacharya, Yun Li, Michael I. Love
PLoS Genetics (2021) Vol. 17, Iss. 3, pp. e1009398-e1009398
Open Access | Times Cited: 66
Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration
Meng‐Shan Tan, Yu‐Xiang Yang, Wei Xu, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 56
Proteomic profiling of circulating plasma exosomes reveals novel biomarkers of Alzheimer’s disease
Huimin Cai, Yana Pang, Qi Wang, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 46
Nose to Brain Delivery of Astaxanthin–Loaded Nanostructured Lipid Carriers in Rat Model of Alzheimer’s Disease: Preparation, in vitro and in vivo Evaluation
Mustafa K Shehata, Assem A Ismail, Maher A. Kamel
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 1631-1658
Open Access | Times Cited: 35
ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker
Patrícia Regina Manzine, Miren Ettcheto, Amanda Cano, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 113, pp. 108661-108661
Open Access | Times Cited: 72
Mechanisms of receptor shedding in platelets
Samantha J. Montague, Robert K. Andrews, Elizabeth E. Gardiner
Blood (2018) Vol. 132, Iss. 24, pp. 2535-2545
Open Access | Times Cited: 64
The Role of Non-coding RNAs in Alzheimer’s Disease: From Regulated Mechanism to Therapeutic Targets and Diagnostic Biomarkers
Yuan Zhang, Yanfang Zhao, Xiang Ao, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 50
Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer’s Disease
Namdoo Kim, Hyuck Jin Lee
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7697-7697
Open Access | Times Cited: 42
The emerging role of furin in neurodegenerative and neuropsychiatric diseases
Yi Zhang, Xiaoqin Gao, Xue Bai, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 36
miR-30a-5p induces Aβ production via inhibiting the nonamyloidogenic pathway in Alzheimer’s disease
Ting Sun, Kaiyue Zhao, Mimin Liu, et al.
Pharmacological Research (2022) Vol. 178, pp. 106153-106153
Closed Access | Times Cited: 34
Page 1 - Next Page

Scroll to top